Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine) (BAT<sup>®</sup>) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review

Use of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine) (BAT<sup>®</sup>) in Clinical Study Subjects and Patients: A 15-Year Systematic Safety Review

Botulism is a rare, sometimes fatal paralytic illness caused by botulinum neurotoxins. BAT<sup>®</sup> (Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)—(Equine)) is an equine-derived heptavalent botulinum antitoxin indicated for the treatment of symptomatic botulism in adult and ped...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Geraldine S. Parrera, Hugo Astacio, Priya Tunga, Deborah M. Anderson, Christine L. Hall, Jason S. Richardson
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2021-12-01
Sarja:Toxins
Aiheet:
safety review
equine-derived
Botulism Antitoxin Heptavalent
BAT product
botulism
Linkit:https://www.mdpi.com/2072-6651/14/1/19

Internet

https://www.mdpi.com/2072-6651/14/1/19

Samankaltaisia teoksia